TAO Synergies Inc TAOX

US Technology
$3.29 โ–ผ -2.66% ($-0.09)
🎈 Low Float
Open $3.41
Prev Close $3.38
Day Range $3.22 โ€“ $3.64
52W Range $3.18 โ€“ $10.00
Market Cap $24.58M
Beta 1.46
EPS (TTM) $-13.32

๐Ÿ“‹ Company Profile

IndustryTechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2020-12-07
Shares Out.7,470,000
Websitesynaptogen.com/ โ†—
Phone19732420005
Employees4
Revenue$388,774
Gross Profit$388,774
Net Income$4.3M
Total Assets$31.0M
Total Liabilities$4.9M
Equity$23.3M
About TAO Synergies Inc

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

TAO Synergies Inc is a publicly traded company under the ticker symbol TAOX on the NASDAQ NMS - GLOBAL MARKET, operating in the Technology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

๐Ÿ“Š Analyst Ratings

7 analysts (2025-04-01)

Strong Buy 2
Buy 4
Hold 1

๐Ÿ“ฐ Latest News for TAOX

๐Ÿ‘ฅ Related Stocks